EntiLink™ Reverse Transcriptase-ELK Biotechnology CO.,Ltd.

Products

EntiLink™ Reverse Transcriptase

EQ002

Specification：	Price：
10000 U	$38.00
40000 U	$111.00

Download ①

OverviewPublications

Product name:	EntiLink™ Reverse Transcriptase
Introduction:	EntiLink™ Reverse Transcriptase is a reverse transcriptase (MMLV RT) obtained by genetic engineering technology to recombine Moloney murine leukemia virus. It has good heat resistance, can withstand reaction temperatures up to 55 °C, Efficient synthesis of full-length first-strand cDNA up to 13kb, suitable for reverse transcription of complex secondary structure RNA templates, provides broader gene representation and superior qRT-PCR sensitivity.
Advantage:	1. No RNaseH activity2. Excellent specificity3. Highly efficient synthesis of full-length first-strand cDNA up to 13 kb4. Can withstand up to 55 ° C reaction temperature5. Suitable for complex secondary structure RNA template reverse transcription

International Journal of Medical Sciences

Left Stellate Ganglion Ablation Inhibits Ventricular Arrhythmias through Macrophage Regulation in Canines with Acute Ischemic Stroke

Date：2021-10-20 IF：2.557
Frontiers in Oncology

The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug

Date：2021-10-26 IF：4.848
Frontiers in Oncology

Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway

Date：2021-10-26 IF：4.848
HISTOLOGY AND HISTOPATHOLOGY

Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA

Date：2021-10-26 IF：1.94
Poultry Science

The mediation of pigeon egg production by regulating the steroid hormone biosynthesis of pigeon ovarian granulosa cells

Date：2021-10-26 IF：2.675
International Journal of Medical Sciences

Left Stellate Ganglion Ablation Inhibits Ventricular Arrhythmias through Macrophage Regulation in Canines with Acute Ischemic Stroke

Date：2021-10-26 IF：2.557
International Journal of Stem Cells

Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells

Date：2021-10-26 IF：-
OncoTargets and Therapy

MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest

Date：2021-10-26 IF：3.259
Biosci Rep

Circadian rhythm and Period2 regulate the chemotherapy effect and multidrug resistance of ovarian cancer through PI3K signaling pathway

Date：2021-10-27 IF：2.897
Molecular Medicine Reports

Molecular mechanism of extracellular matrix disorder in pelvic organ prolapses

Date：2021-10-27 IF：2.085
MEDICAL SCIENCE MONITOR

Salidroside Suppresses IL-1β-Induced Apoptosis in Chondrocytes via Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Inhibition

Date：2021-12-22 IF：1.947
MOLECULAR VISION

MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells

Date：2021-12-22 IF：2.213
Cancer Management and Research

Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer

Date：2020-11-19 IF：3.989
Translational Psychiatry

proBDNF expression induces apoptosis and inhibits synaptic regeneration by regulating the RhoA-JNK pathway in an in vitro post-stroke depression model

Date：2021-09-24 IF：6.222
research square

Exosome Derived From Traumatic Brain Injury Patients Accelerates Fracture Healing via SMAD7 Signaling Regulation

Date：2021-11-15 IF：-
Frontiers in Oncology

The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug

Date：2020-02-15 IF：6.244
Oxidative Medicine and Cellular Longevity

Novel Role of miR-18a-5p and Galanin in Rat Lung Ischemia Reperfusion-Mediated Response

Date：2021-08-17 IF：6.543
Bioengineered

Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4

Date：2022-02-24 IF：3.269
Molecular Medicine Reports

Nicotine promotes chronic obstructive pulmonary disease via inducing pyroptosis activation in bronchial epithelial cells

Date：2022-01-18 IF：2.952
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES

Preliminary exploration of the potential of spliceosome-associated protein 130 for predicting disease severity in Crohn's disease

Date：2021-05-04 IF：5.691
Journal of Crohns & Colitis

Mincle/Syk Signalling Promotes Intestinal Mucosal Inflammation Through Induction of Macrophage Pyroptosis in Crohn's Disease

Date：2020-04-25 IF：9.071
Molecular Medicine Reports

Molecular mechanism of extracellular matrix disorder in pelvic organ prolapses

Date：2020-10-06 IF：2.952
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Exploration of YY1 in the Regulation of Trophoblast Function Through TGF-β1 Signal Axis

Date：2020-02-15 IF：3.561
Gene

Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer

Date：2022-07-02 IF：3.913
European Journal of Histochemistry

VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway

Date：2022-10-27 IF：1.966
European Journal of Histochemistry

Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNALINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel viatargeting miR-200b-3p/Bcl-2 axis

Date：2022-10-25 IF：1.966
Drug Design Development and Therapy

Exosomes Derived from Hypoxic Glioma Cells Reduce the Sensitivity of Glioma Cells to Temozolomide Through Carrying miR-106a-5p

Date：2022-10-13 IF：4.319
Scientific Reports

Vagus nerve stimulation attenuates acute kidney injury induced by hepatic ischemia/reperfusion injury in rats

Date：2022-08-17 IF：4.996
BMC Medicine

Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors

Date：2023-01-05 IF：11.15
International Journal of Nanomedicine

Exosomal miR-133a-3p Derived from BMSCs Alleviates Cerebral Ischemia-Reperfusion Injury via Targeting DAPK2

Date：2023-01-05 IF：7.033

EQ002 EntiLink™ Reverse Transcriptase_01.png